ES2107118T3 - Procedimiento para la preparacion de diesteres cuaternarios. - Google Patents

Procedimiento para la preparacion de diesteres cuaternarios.

Info

Publication number
ES2107118T3
ES2107118T3 ES94202451T ES94202451T ES2107118T3 ES 2107118 T3 ES2107118 T3 ES 2107118T3 ES 94202451 T ES94202451 T ES 94202451T ES 94202451 T ES94202451 T ES 94202451T ES 2107118 T3 ES2107118 T3 ES 2107118T3
Authority
ES
Spain
Prior art keywords
carbon atoms
atom
group
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94202451T
Other languages
English (en)
Inventor
Burkhard Weuste
Hans Joachim Weissen
Andrea Gertrud Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2107118T3 publication Critical patent/ES2107118T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups

Abstract

SE PRESENTA UN PROCESO PARA LA PREPARACION DE DIESTERES CUATERNARIOS DE LA FORMULA: (I) EN LA QUE X- REPRESENTA UN ATOMO DE HALOGENO, NOTABLEMENTE UN ATOMO DE CLORO O UN ATOMO DE BROMO; R1 Y R2 PUEDEN SER IGUALES O DIFERENTES Y TIENEN EL SIGNIFICADO DE UN GRUPO QUE TIENEN ENTRE 1 Y 3 ATOMOS DE CARBONO, UN GRUPO DE HIDROXIETILO, O PUEDEN ESTAR UNIDAS PARA FORMAR UN GRUPO DE ALQUILENO QUE TENGA ENTRE 4 Y 6 ATOMOS DE CARBONO QUE PUEDE ESTAR INTERRUMPIDO POR UN ATOMO DE N O UN ATOMO DE O, Y R3 Y R4 PUEDEN SER IGUALES O DIFERENTES Y TIENEN EL SIGNIFICADO DE UN GRUPO DE ALQUILO O UN GRUPO DE ALQUENILO QUE TIENE ENTRE 8 Y 22 ATOMOS DE CARBONO, O PUEDEN ESTAR UNIDAS ENTRE SI PARA FORMAR UN GRUPO DE ALK(EN)ILENO QUE TENGA ENTRE 8 Y 22 ATOMOS DE CARBONO, QUE SE CARACTERIZA EN QUE: A) UN AMINO SECUNDARIO DE LA FORMULA R{SUB, 1}-NH-R{SUB, 2} SE AÑADE GRADUALMENTE Y CONVIERTE CON UNO O MAS COMPUESTOS LIQUIDOS DE LA FORMULA II O III EN UNA PROPORCION MOLAR EN LA BANDA DE ENTRE 1,0:1,0 Y 1,0:1,2 DESPUES DE LO CUAL B) EL HIDROHALURO DE AMINO SOLIDO FORMADO SE SEPARA SIGUIENTE POR C) UN POSTRATAMIENTO, OPCIONALMENTE EN UN SOLVENTE, A ELEVADA TEMPERATURA HASTA QUE LA CONVERSION ESTE VIRTUALMENTE COMPLETA, DESPUES DE LO CUAL, SI SE DESEA, UN TRATAMIENTO ADICIONAL, TAL COMO LA RECRISTALIZACION A PARTIR DE UN SOLVENTE ORGANICO, SE LLEVA A CABO PARA CONSEGUIR UNA FORMA DE PRODUCTO ESPECIAL.
ES94202451T 1994-08-29 1994-08-29 Procedimiento para la preparacion de diesteres cuaternarios. Expired - Lifetime ES2107118T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94202451A EP0699655B1 (en) 1994-08-29 1994-08-29 Process for the preparation of quaternary diesters

Publications (1)

Publication Number Publication Date
ES2107118T3 true ES2107118T3 (es) 1997-11-16

Family

ID=8217141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94202451T Expired - Lifetime ES2107118T3 (es) 1994-08-29 1994-08-29 Procedimiento para la preparacion de diesteres cuaternarios.

Country Status (7)

Country Link
US (1) US5596125A (es)
EP (1) EP0699655B1 (es)
JP (1) JPH0867658A (es)
AT (1) ATE158568T1 (es)
CA (1) CA2157096A1 (es)
DE (1) DE69405864T2 (es)
ES (1) ES2107118T3 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032625A1 (en) 1999-11-03 2001-05-10 Du Pont Pharmaceuticals Company Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
US7084152B2 (en) 2000-07-11 2006-08-01 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
WO2006020049A2 (en) 2004-07-15 2006-02-23 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ATE550019T1 (de) 2005-05-17 2012-04-15 Merck Sharp & Dohme Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
KR101589551B1 (ko) 2005-07-15 2016-02-02 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
DK2805945T3 (da) 2007-01-10 2019-07-15 Msd Italia Srl Amid-substituerede indazoler som poly(adp-ribose)polymerase- (parp) hæmmere
EP2170076B1 (en) 2007-06-27 2016-05-18 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US8691825B2 (en) 2009-04-01 2014-04-08 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
MX2011011907A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc 7-([1,2,4,]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2, 3,4-tetrahidroisoquinolina y uso de la misma.
AU2010247735B2 (en) 2009-05-12 2015-07-16 Albany Molecular Research, Inc. Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof
ES2446971T3 (es) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
UA109417C2 (uk) 2009-10-14 2015-08-25 Мерк Шарп Енд Доме Корп. ЗАМІЩЕНІ ПІПЕРИДИНИ, ЯКІ ПІДВИЩУЮТЬ АКТИВНІСТЬ p53, І ЇХ ЗАСТОСУВАННЯ
EP3330377A1 (en) 2010-08-02 2018-06-06 Sirna Therapeutics, Inc. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
KR102072631B1 (ko) 2010-08-17 2020-02-03 시르나 쎄러퓨틱스 인코퍼레이티드 짧은 간섭 핵산 （ｓｉＮＡ）을 사용한 Ｂ형 간염 바이러스 （ＨＢＶ） 유전자 발현의 ＲＮＡ 간섭 매개 억제
EP2608669B1 (en) 2010-08-23 2016-06-22 Merck Sharp & Dohme Corp. NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
EP2613782B1 (en) 2010-09-01 2016-11-02 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
US9260471B2 (en) 2010-10-29 2016-02-16 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
WO2012087772A1 (en) 2010-12-21 2012-06-28 Schering Corporation Indazole derivatives useful as erk inhibitors
CN103732592A (zh) 2011-04-21 2014-04-16 默沙东公司 ***-1受体抑制剂
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
EP3358013B1 (en) 2012-05-02 2020-06-24 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
US9233979B2 (en) 2012-09-28 2016-01-12 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
CA2892361A1 (en) 2012-11-28 2014-06-05 Merck Sharp & Dohme Corp. Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels
WO2014100065A1 (en) 2012-12-20 2014-06-26 Merck Sharp & Dohme Corp. Substituted imidazopyridines as hdm2 inhibitors
US9540377B2 (en) 2013-01-30 2017-01-10 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
EP3706742B1 (en) 2017-11-08 2023-03-15 Merck Sharp & Dohme LLC Prmt5 inhibitors
EP3833668A4 (en) 2018-08-07 2022-05-11 Merck Sharp & Dohme Corp. PRMT5 INHIBITORS
US20210309688A1 (en) 2018-08-07 2021-10-07 Merck Sharp & Dohme Corp. Prmt5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2926772A1 (de) * 1979-07-03 1981-01-15 Hoechst Ag Quaternaere alkylamino-di-alkylcarbonsaeure-di-ester, verfahren zu deren herstellung und deren verwendung
JPH08501074A (ja) * 1992-06-10 1996-02-06 ザ、プロクター、エンド、ギャンブル、カンパニー 安定な生分解性布帛柔軟化化合物および組成物

Also Published As

Publication number Publication date
EP0699655A1 (en) 1996-03-06
EP0699655B1 (en) 1997-09-24
CA2157096A1 (en) 1996-03-01
JPH0867658A (ja) 1996-03-12
DE69405864T2 (de) 1998-03-26
DE69405864D1 (de) 1997-10-30
ATE158568T1 (de) 1997-10-15
US5596125A (en) 1997-01-21

Similar Documents

Publication Publication Date Title
ES2107118T3 (es) Procedimiento para la preparacion de diesteres cuaternarios.
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
NO955023L (no) Piperidinderivater og fremgangsmåte for fremstilling derav
DK0979821T3 (da) Tricykliske forbindelser
BR9508037A (pt) Derivados de piridona-ácido carboxilico agente anti-tumor composição farmacológica e processo para preparar derivados de piridona-ácido carboxilico
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
DE69305045T2 (de) N-Alkoxymethylbenzamid-Derivate und Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Benzamid-Derivaten
NO911896D0 (no) Umettede polyesterharpikser og fremgangsmaate for fremstilling av harpiksene.
PT99043A (pt) Processo para a preparacao de composicoes biocidas contendo derivados de 4,5-polimetileno-4-isotiazolin-3-onas
ES2054675T3 (es) Un procedimiento para la preparacion de isotiazolonas.
DE3765206D1 (de) Substituierte 2-aminotetraline.
ES2099727T3 (es) 8-azabiciclo(3.2.1)octilalquiltiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
ES2089097T3 (es) Procedimiento para la fabricacion de derivados de bencilftalacinona y sales de la misma.
DE69204480D1 (de) Anilinderivate und Verfahren zu ihrer Herstellung.
DE69016266T2 (de) Aminoketonverbindungen.
DE69007203T2 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
FI882956A (fi) 4-piperidyl-substituerade karboxylsyraderivat och foerfarande foer deras framstaellning.
BR8706887A (pt) Processo para a preparacao de compostos
ES2188478T3 (es) Procedimiento para la preparacion de un 1,1,1-trifluor-2-aminoalcano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 699655

Country of ref document: ES